Breaking News Instant updates and real-time market news.

FORM

FormFactor

$13.20

-0.4 (-2.94%)

16:24
02/07/18
02/07
16:24
02/07/18
16:24

FormFactor sees Q1 EPS 12c-18c, consensus 20c

Sees Q1 revenue $112M-$120M, consensus $120.6M. Mike Slessor, CEO of FormFactor, said, "consistent with commentary provided on January 17th, we are experiencing a delay in probe card demand from our largest customer, pushing expected revenue from the first quarter into the second quarter of 2018. As a result, we are currently forecasting that our first quarter 2018 revenue will be lower than the $131.9 million reported in the fourth quarter of 2017."

FORM FormFactor
$13.20

-0.4 (-2.94%)

08/03/17
DADA
08/03/17
NO CHANGE
DADA
FormFactor 'firing on all cylinders,' says DA Davidson
DA Davidson analyst Thomas Diffely says that FormFactor is "firing on all cylinders," and reported its "best quarter in ten years." The analyst remains very upbeat on the stock and keeps a Buy rating.
08/31/17
DADA
08/31/17
NO CHANGE
DADA
FormFactor risk/reward ratio positive, says DA Davidson
After meeting with FormFactor's management, DA Davidson analyst Thomas Diffely says that the company's "near term business trends continue to strengthen and the long term outlook has never been better," The analyst says that expectations for the company are "fairly modest," as the market has failed to fully appreciate significant improvements that FormFactor has made, and he expects the company's earnings to beat expectations. As a result, he thinks that the stock's risk/reward ratio is "bullish," and he keeps a Buy rating on the shares.
12/14/17
NEED
12/14/17
UPGRADE
NEED
Strong Buy
FormFactor upgraded to Strong Buy from Buy at Needham
12/15/17
NEED
12/15/17
UPGRADE
Target $22
NEED
Strong Buy
FormFactor upgraded to Strong Buy at Needham on foundry share gains
As noted earlier, Needham analyst Y. Edwin Mok upgraded FormFactor to Strong Buy from Buy and raised his price target to $22 from $20. Mok says FormFactor is his "Top Pick for 2018" in the space based on his "expectation for solid demand, share gains in foundry/logic and low expectations set by conservative consensus estimates". The analyst says the company should command higher multiple based on its "consumables-oriented business model" and the growth trends of AP, Mobile Data, and Auto industries.

TODAY'S FREE FLY STORIES

IPXL

Impax

$19.70

0.1 (0.51%)

07:54
02/21/18
02/21
07:54
02/21/18
07:54
Hot Stocks
Amneal launches memantine hydrochloride extended-release capsules »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

PTCT

PTC Therapeutics

$24.14

0.21 (0.88%)

07:54
02/21/18
02/21
07:54
02/21/18
07:54
Recommendations
PTC Therapeutics analyst commentary  »

PTC Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

X

U.S. Steel

$44.83

0.08 (0.18%)

07:52
02/21/18
02/21
07:52
02/21/18
07:52
Recommendations
U.S. Steel analyst commentary  »

U.S. Steel price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DX

Dynex Capital

$6.28

-0.1 (-1.57%)

07:52
02/21/18
02/21
07:52
02/21/18
07:52
Earnings
Dynex Capital reports Q4 core EPS 20c, consensus 19c »

Book value per common…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACIA

Acacia Communications

$41.92

-0.48 (-1.13%)

07:51
02/21/18
02/21
07:51
02/21/18
07:51
Recommendations
Acacia Communications analyst commentary  »

Acacia Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 29

    Mar

RGR

Sturm, Ruger

$48.35

-1.95 (-3.88%)

, AOBC

American Outdoor Brands

$10.18

-0.56 (-5.21%)

07:50
02/21/18
02/21
07:50
02/21/18
07:50
Periodicals
President Trump urges ban of bump stocks, CNBC reports »

President Donald Trump on…

RGR

Sturm, Ruger

$48.35

-1.95 (-3.88%)

AOBC

American Outdoor Brands

$10.18

-0.56 (-5.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 01

    Mar

WYNN

Wynn Resorts

$164.92

0.64 (0.39%)

07:50
02/21/18
02/21
07:50
02/21/18
07:50
Recommendations
Wynn Resorts analyst commentary  »

Okada case could have $4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QUOT

Quotient Technology

$13.30

0.1 (0.76%)

07:49
02/21/18
02/21
07:49
02/21/18
07:49
Initiation
Quotient Technology initiated  »

Quotient Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$41.00

-1.54 (-3.62%)

, NFLX

Netflix

$278.55

0.03 (0.01%)

07:47
02/21/18
02/21
07:47
02/21/18
07:47
Periodicals
Judge rejects VW's bid to delay first U.S. diesel emissions trial, Reuters says »

A judge has denied a…

VLKAY

Volkswagen

$41.00

-1.54 (-3.62%)

NFLX

Netflix

$278.55

0.03 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 20

    Mar

MMLP

Martin Midstream Partners

$16.05

-0.2 (-1.23%)

07:47
02/21/18
02/21
07:47
02/21/18
07:47
Conference/Events
Martin Midstream Partners to hold a guidance conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

MOS

Mosaic

$26.76

1.33 (5.23%)

07:46
02/21/18
02/21
07:46
02/21/18
07:46
Technical Analysis
Technical Take: Mosaic moves higher, analyst action »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

SWDBY

Swedbank

$25.49

-0.43 (-1.66%)

07:46
02/21/18
02/21
07:46
02/21/18
07:46
Conference/Events
Swedbank management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 23

    Feb

MDR

McDermott

$7.89

0.04 (0.51%)

07:46
02/21/18
02/21
07:46
02/21/18
07:46
Earnings
McDermott sees FY18 sees FY18 EPS 42c-52c, consensus 46c »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

OKTA

Okta

$35.84

1.09 (3.14%)

07:45
02/21/18
02/21
07:45
02/21/18
07:45
Recommendations
Okta analyst commentary  »

Okta price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 07

    Mar

K

Kellogg

$69.68

0.02 (0.03%)

07:44
02/21/18
02/21
07:44
02/21/18
07:44
Hot Stocks
Kellogg affirms 2018 guidance and plan, including 2018 adjusted EPS up 9%-11% »

In slides being presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

MDR

McDermott

$7.89

0.04 (0.51%)

07:44
02/21/18
02/21
07:44
02/21/18
07:44
Earnings
McDermott reports Q4 EPS 10c, consensus 4c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

PTLA

Portola Pharmaceuticals

$48.22

0.53 (1.11%)

07:43
02/21/18
02/21
07:43
02/21/18
07:43
Recommendations
Portola Pharmaceuticals analyst commentary  »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 04

    May

HD

Home Depot

$186.71

-0.26 (-0.14%)

07:43
02/21/18
02/21
07:43
02/21/18
07:43
Recommendations
Home Depot analyst commentary  »

Home Depot price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

GPC

Genuine Parts

$94.67

-5.16 (-5.17%)

07:39
02/21/18
02/21
07:39
02/21/18
07:39
Recommendations
Genuine Parts analyst commentary  »

Genuine Parts price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

OC

Owens Corning

$87.15

-0.325 (-0.37%)

07:38
02/21/18
02/21
07:38
02/21/18
07:38
Hot Stocks
Owens Corning expects FY18 corporate expenses $140M-$150M »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

FSLR

First Solar

$66.58

0.73 (1.11%)

07:37
02/21/18
02/21
07:37
02/21/18
07:37
Hot Stocks
First Solar to build 200MWac solar plant in Twiggs County, GA »

First Solar is set to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 15

    Mar

TTS

Tile Shop

07:37
02/21/18
02/21
07:37
02/21/18
07:37
Earnings
Tile Shop reports Q4 EPS (5c), consensus 5c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

WMT

Walmart

$94.11

-10.67 (-10.18%)

07:37
02/21/18
02/21
07:37
02/21/18
07:37
Recommendations
Walmart analyst commentary  »

Walmart should be bought…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

  • 07

    Mar

  • 18

    Mar

HALO

Halozyme

$18.48

-0.06 (-0.32%)

07:37
02/21/18
02/21
07:37
02/21/18
07:37
Recommendations
Halozyme analyst commentary  »

Halozyme pipeline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Apr

  • 10

    Apr

  • 11

    Apr

  • 12

    Apr

EROS

Eros International

$13.30

0.6 (4.72%)

07:36
02/21/18
02/21
07:36
02/21/18
07:36
Hot Stocks
Eros International sees reaching 6-8M paying Eros Now subscribers by March 31 »

Prem Parameswaran, Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 05

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.